Thyroglobulin (TG)
Thyroglobulin is a protein produced exclusively by the thyroid gland. After thyroid cancer treatment, TG serves as a tumour marker to detect recurrence. Anti-TG antibodies should be tested simultaneously.
- DHA-licensed lab
- Includes Doctor Consultation
- Physician-reviewed
- Same Day Collection
24 hours
Turnaround
Blood
Sample
What the Thyroglobulin (TG) test tells you
Thyroglobulin is a large protein that the thyroid gland uses as scaffolding to build thyroid hormone. It is stored inside the gland's follicles, and small amounts spill into the blood in anyone with functioning thyroid tissue. No other organ makes it, and it has no role outside the thyroid: that exclusivity is what gives the test its purpose.
Its main use follows treatment for differentiated thyroid cancer, the papillary and follicular types. Once the whole gland has been removed surgically and any remaining thyroid tissue destroyed with radioactive iodine, there should be essentially no source of thyroglobulin left in the body. A measurable value afterwards, and more importantly a value that climbs across successive samples, suggests thyroid cells have persisted or returned, and prompts scanning to find them. Followed at intervals over years, it is the most sensitive routine blood marker available in this setting. It is not a screening test: it cannot tell whether a nodule in an untreated thyroid is cancerous, and it has no role in looking for thyroid cancer in the general population.
One technical caveat dominates its interpretation, and it links this test to another. A substantial number of people carry anti-thyroglobulin antibodies, and those antibodies bind the protein in the sample and interfere with the measurement: usually pushing the reported value down and potentially concealing disease that is present. An antibody-positive result therefore makes the thyroglobulin figure unreliable, which is why the two are almost always run together on the same sample. When antibodies are present, specialists often track the antibody level itself as a surrogate, since it tends to fall as disease clears and to rise if it comes back.
Primary tumour marker for monitoring differentiated thyroid cancer (papillary and follicular) after treatment. Not useful as a screening test.
- Surveillance after thyroidectomy
In treated differentiated thyroid cancer, thyroglobulin is the main blood marker used to look for residual or returning disease.
- Judging treatment completeness
A fall to undetectable after surgery and radioiodine supports that the thyroid tissue targeted has been cleared.
- Detecting recurrence early
A value that begins to climb across successive samples often precedes anything visible on a scan.
- Interpreting thyroid imaging
When a neck scan shows something uncertain, the thyroglobulin trend helps your specialist judge how likely it is to be active disease.
Reasons your doctor may request the Thyroglobulin (TG) test
Your doctor may order this test for any of the reasons below. Some are routine checks, others follow specific symptoms or an earlier result.
After thyroid cancer treatment
- You have had surgery for papillary or follicular thyroid cancer and are in long-term follow-up.
- You have completed radioactive iodine treatment and your team is confirming the response.
- Your specialist is assessing whether thyroid tissue remains after treatment.
Ultrasound findings & unusual thyroid overactivity
- A neck ultrasound has shown a finding that needs putting into context.
- An unusual cause of an overactive thyroid is being investigated and thyroglobulin helps distinguish the mechanism.
What counts as reassuring depends on whether you still have a thyroid. With the gland intact, a result in the Reference range, 1.4 to 78 ng/mL, simply reflects working thyroid tissue, while a result in the High band, 79 to 1000 ng/mL, is common with a goitre or nodular gland, with thyroiditis or Graves' disease, and briefly after surgery, biopsy or radioiodine. After treatment for thyroid cancer the aim is the opposite: with the gland removed and any remnant ablated, a value inside the Reference range can still be a concern, and the trend across samples matters more than any single figure. Anti-thyroglobulin antibodies bind the protein and push the reported value down, which is why the two are measured together and why an antibody-positive result is unreliable. Methods are not comparable between laboratories, so stay with one. Your doctor reads the trend with your treatment history.
Medically reviewed by Dr Nirupama Sabhapathy
Ranges are a guide: your physician interprets your result alongside your symptoms and history.
What a higher result can point to
- Residual or recurrent differentiated thyroid cancer after treatment.
- Thyroid tissue left behind after surgery that has not yet been ablated.
- Thyroiditis or any inflammation that releases stored protein from the gland.
- Goitre or a large nodular thyroid in someone whose gland is still intact.
- Recent thyroid surgery, biopsy or radioiodine, which release the protein transiently.
- Graves' disease and other causes of a stimulated, overactive gland.
What a lower result can point to
- Successful removal and ablation of thyroid tissue, which is the intended result when the test is used to monitor treated thyroid cancer.
- Absence of functioning thyroid tissue from birth, a rare finding picked up in newborn screening.
- Interfering anti-thyroglobulin antibodies, which can mask the protein and make the result read lower than it truly is.
- Thyroid hormone treatment that suppresses the gland's activity and with it the protein it releases.
These are possibilities, not diagnoses. A single value outside the reference range is interpreted alongside your symptoms, history and other tests: your doctor decides what it means for you.
What this test cannot tell you
- Anti-thyroglobulin antibodies interfere with the assay and can produce a falsely low result, so an antibody-positive sample makes the thyroglobulin value unreliable and the two must be measured together.
- Results are assay-dependent and are not comparable between laboratories, so follow-up should stay with a single laboratory.
- The test cannot tell whether a nodule in an untreated thyroid is cancerous and has no role in population screening.
- An undetectable result after successful treatment is the desired outcome, not a deficiency to be corrected.
Risks of the blood draw
- Mild bruising or brief soreness where the needle went in.
- Occasional lightheadedness, which settles after a few minutes of rest.
- Bleeding or infection at the site, which is rare with sterile single-use equipment.
- 1Only thyroid tissue makes thyroglobulin, which is what makes it useful once the gland has been removed.
- 2The trend across repeated samples matters more than any single figure.
- 3Anti-thyroglobulin antibodies must be measured on the same sample or the result cannot be trusted.
- 4A low or undetectable value after thyroid cancer treatment is what your team is hoping for.
- 5It is a follow-up marker, never a way to screen for thyroid cancer.
- EndocrinologyAnti-Thyroglobulin Antibody (Anti-TG)
Anti-TG measures antibodies against thyroglobulin, a key protein in thyroid hormone production. Elevated levels may suggest autoimmune thyroid…
95View - EndocrinologyThyroid Stimulating Hormone (TSH)
TSH is the most sensitive test for thyroid function. Produced by the pituitary gland, it controls thyroid hormone production. High TSH suggests…
35View - EndocrinologyThyroxine, Free (FT4)
Free T4 measures the active, unbound form of the main thyroid hormone. Along with TSH, it is essential for diagnosing thyroid disorders and adjusting…
35View - EndocrinologyAnti-Thyroid Peroxidase Antibody (Anti-TPO)
Anti-TPO detects antibodies against thyroid peroxidase, an enzyme essential for thyroid hormone synthesis. High levels are strongly linked to…
95View
Frequently Asked Questions
Everything you need to know about the Thyroglobulin (TG) test. Can't find what you're looking for?
Talk to our team→Our laboratory reports 1.4 to 78 ng/mL as the reference range and 79 to 1000 ng/mL as high, but what counts as reassuring depends on whether you still have a thyroid. With the gland intact, a value in the reference range simply reflects working thyroid tissue. After thyroid cancer treatment the aim is a low or undetectable value, so a figure inside the range can still be a concern.
Because only thyroid tissue makes thyroglobulin, a rising trend after surgery and ablation suggests thyroid cells are present, either remaining tissue that has not yet been ablated or residual or recurrent differentiated thyroid cancer. The direction across repeated samples from the same laboratory matters more than any one figure, and antibody status must be known. Your specialist reads the trend with your treatment history.
In someone whose thyroid is still in place, a high value is common and usually reflects the gland itself. A goitre or large nodular thyroid, thyroiditis, Graves' disease and other causes of an overactive gland all raise it, and recent thyroid surgery, biopsy or radioiodine release the protein briefly. It cannot show whether a nodule is cancerous and is not a screening test.
Thyroglobulin results depend on the assay platform and cannot be compared directly between laboratories. Since follow-up after thyroid cancer rests on the trend across samples, switching laboratories can create an apparent rise or fall that is really a difference in method. Using one laboratory throughout keeps each new value comparable with the last.
Yes. High-dose biotin supplements can interfere with the assay, so mention them when you give the sample. Thyroid surgery, biopsy and radioiodine release thyroglobulin temporarily, so allow the interval your specialist advises before testing. Thyroid hormone treatment that suppresses the gland can also lower the value, which your specialist takes into account.
Because anti-thyroglobulin antibodies bind the protein in the tube and stop the assay from detecting it properly. Without knowing whether they are present, a low thyroglobulin result cannot be trusted to mean there is no disease.
After the thyroid has been removed and treated with radioiodine, undetectable is exactly what your team wants to see. It suggests no thyroid tissue is releasing the protein, and it is the reassuring result rather than a deficiency.
No. In a gland that is still in place, thyroglobulin reflects how much thyroid tissue there is and how active it is, not whether any of it is malignant. Nodules are assessed with ultrasound and, where indicated, a needle sample.
Some protocols deliberately raise TSH, either by pausing hormone replacement or by giving a stimulating injection, because that makes any surviving thyroid cells release more thyroglobulin and easier to detect. It is a way of making the test more sensitive.
No. No fasting is needed, and you can take your thyroid hormone tablet as usual unless your specialist has told you otherwise. Check that anti-thyroglobulin antibodies have been requested on the same sample.
The thyroglobulin test is AED 80, including a physician-reviewed report, with results usually within 24 hours. Home collection anywhere in Dubai is free when your order reaches AED 300 or includes a package; below that, a AED 100 home collection fee applies (AED 50 for a lab walk-in).